InvestSMART

Pro Medicus Limited (ASX: PME) - Announcements

Current share price for PME : $202.570 0.22 (0.11%)+

ASX company news and announcements for Pro Medicus Limited (PME) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Pro Medicus Limited (PME) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Pro Medicus Limited (PME), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Pro Medicus Limited (PME)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$21,162 Change of Director's Interest Notice - Peter Kempen 9 Nov 2026 1:16PM $204.580 $202.570 fallen by 0.98%
$21,162 Becoming a substantial holder 28 Oct 2026 7:46PM $196.000 $202.570 risen by 3.35%
$21,162 Notice of Annual General Meeting and Proxy Form 23 Oct 2026 10:10AM $194.270 $202.570 risen by 4.27%
$21,162 PME signs A$43M, 7-year contract with Virtua Health 21 Oct 2026 8:19AM $179.930 $202.570 risen by 12.58%
$21,162 PME signs AUD $24M, 7-year contract with Billings Clinic 19 Oct 2026 8:41AM $175.730 $202.570 risen by 15.27%
$21,162 Pro Medicus Ltd - 2026 AGM Date 1 Oct 2026 11:08AM $160.670 $202.570 risen by 26.08%
$21,162 Pro Medicus Ltd Appoints Non-Executive Director 23 Sep 2026 8:20AM $164.330 $202.570 risen by 23.27%
$21,162 Ceasing to be a substantial holder 7 Sep 2026 6:49PM $168.610 $202.570 risen by 20.14%
$21,162 PME signs 7-year, A$25M contract with Valley Health 21 Aug 2026 8:25AM $206.010 $202.570 fallen by 1.67%
$21,162 Annual Report FY26 18 Aug 2026 10:05AM $180.190 $202.570 risen by 12.42%
$21,162 PME FY26 results presentation 18 Aug 2026 9:44AM $175.860 $202.570 risen by 15.19%
$21,162 CEO Interview FY26 Results 18 Aug 2026 9:36AM $175.860 $202.570 risen by 15.19%
$21,162 Appendix 4G 18 Aug 2026 9:34AM $175.860 $202.570 risen by 15.19%
$21,162 Dividend/Distribution - PME 18 Aug 2026 9:34AM $175.860 $202.570 risen by 15.19%
$21,162 2026 Corporate Governance Statement 18 Aug 2026 9:34AM $175.860 $202.570 risen by 15.19%
$21,162 PME Full Year Results 18 Aug 2026 9:32AM $175.860 $202.570 risen by 15.19%
$21,162 Preliminary Final Report FY26 (Appendix 4E) 18 Aug 2026 9:31AM $175.860 $202.570 risen by 15.19%
$21,162 PME signs Convertible Note agreement with Echo IQ 17 Aug 2026 9:22AM $178.860 $202.570 risen by 13.26%
$21,162 PME signs A$23M, 7-year contract with St Luke's Health 12 Aug 2026 9:13AM $182.330 $202.570 risen by 11.10%
$21,162 PME FY26 Results release date and webcast briefing 16 Jul 2026 10:30AM $192.540 $202.570 risen by 5.21%
$21,162 PME announces appointment Head of Investor Relations 8 Jul 2026 9:39AM $210.740 $202.570 fallen by 3.88%
$21,162 PME signs HoA Echo IQ Finance Facility & Reseller Agreement 25 Jun 2026 9:07AM $178.990 $202.570 risen by 13.17%
$21,162 EIQ: Binding HOA secured with Pro Medicus Limited 25 Jun 2026 8:51AM $178.990 $202.570 risen by 13.17%
$21,162 S&P DJI Announces June 2026 Quarterly Rebalance 5 Jun 2026 5:12PM $165.640 $202.570 risen by 22.30%
$21,162 PME signs 5-year, A$16M contract renewal with OSU 4 Jun 2026 8:24AM $159.630 $202.570 risen by 26.90%

1 - 25 of 687 results

Page 1 of 28

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.